首页> 美国卫生研究院文献>Oncotarget >Circulating thyroid stimulating hormone receptor messenger RNA and differentiated thyroid cancer: A diagnostic meta-analysis
【2h】

Circulating thyroid stimulating hormone receptor messenger RNA and differentiated thyroid cancer: A diagnostic meta-analysis

机译:循环甲状腺刺激激素受体信使RNA和分化型甲状腺癌的诊断性荟萃分析

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Thyroid stimulating hormone receptor messenger RNA (TSHR-mRNA) is over-expressed in thyroid cancer patients, which indicates that TSHR-mRNA is a potential biomarker of thyroid cancer. However, system evaluation for TSHR-mRNA as a diagnostic biomarker of thyroid cancer is deficient. The performance of TSHR-mRNA for thyroid cancer diagnosis was evaluated in this study. Three common international databases as well as a Chinese database were applied for literature researching. Quality assessment of the included literatures was conducted by the QUADAS-2 tool. Totally, 1027 patients from nine studies eligible for the meta-analysis were included in this study. Global sensitivity and specificity for the positivity of TSHR-mRNA in the thyroid cancer diagnosis is 72% and 82%. The value of AUC for this test performance was 0.84. Our meta-analysis suggests that TSHR-mRNA might be a potential biomarker to complete present diagnostic methods for early and precision diagnosis of thyroid cancer. Notably, this findings need validation thorough large-scale clinical studies.
机译:甲状腺刺激性激素受体信使RNA(TSHR-mRNA)在甲状腺癌患者中过表达,这表明TSHR-mRNA是甲状腺癌的潜在生物标志物。然而,将TSHR-mRNA作为甲状腺癌的诊断性生物标志物的系统评估不足。本研究评估了TSHR-mRNA在甲状腺癌诊断中的性能。三个常用的国际数据库和中文数据库被用于文献研究。使用QUADAS-2工具对纳入文献进行质量评估。本研究共纳入了来自9项符合荟萃分析的研究的1027例患者。 TSHR-mRNA阳性在甲状腺癌诊断中的总体敏感性和特异性分别为72%和82%。该测试性能的AUC值为0.84。我们的荟萃分析表明,TSHR-mRNA可能是完成目前用于甲状腺癌早期和精确诊断的诊断方法的潜在生物标志物。值得注意的是,这一发现需要通过大规模临床研究进行验证。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号